| [1] |
王昊天，段晶晶，毛洁飞，等. 对于划分同、异时性双侧原发性乳腺癌间隔时间的探讨[J]. 中国癌症杂志，2016，26(2)：193-195.
|
| [2] |
Senkus E, Szade J. Are synchronous and metachronous bilateral breast cancers different? An immunohisto-chemical analysis aimed at intrinsic tumor phenotype [J]. Int J Clin Exp Pathol，2013，7(1)：353-363.
|
| [3] |
Leal C, Henrique R，Monterio P, et al. Apocrine ductal carcinoma in situ of the breast：histologic classification and expression of biologic markers [J]. Hum Pathol，2001，32(5)：487-493.
|
| [4] |
李鹏飞，王跃欣，张松，等. 乳腺大汗腺癌的研究进展[J]．肿瘤研究与临床，2021，33(3)：229-232.
|
| [5] |
Cheang MC, Chia SK, Voduc D，et al. Ki67 index，HER-2 status，and prognosis of patients with luminal B breast cancer[J]．J Natl Cancer Inst，2009，101(10)：736-750.
|
| [6] |
韦常宏，韦薇，林思彤，等. 同时双侧原发性乳腺癌的临床病理特征、分子分型及预后分析[J]．山东医药，2019，59(12)：53-55.
|
| [7] |
阚秀. 乳腺癌临床病理学[M]．北京：北京医科大学中国协和医科大学联合出版社，1993：98-102.
|
| [8] |
丁华野. 乳腺病理诊断和鉴别诊断[M]．北京：人民卫生出版社，2014：296-307.
|
| [9] |
Calhoun BC, Booth CN. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management[J]. Hum Pathol，2014，45(10)：2130-2135.
|
| [10] |
Gucalp A, Tolaney S, Isakoff SJ, et al. Phase Ⅱ trial of bicalutamide in patients with androgen receptor-positive，estrogen receptor-negative metastatic breast cancer[J]. Clin Cancer Res，2013，19(19)：5505-5512.
|
| [11] |
D’Arcy C, Quinn CM. Apocrine lesions of the breast: part 2 of a two-part review：invasive apocrine carcinoma，the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast[J]. J Clin Pathol，2019，72(1)：7-11.
|
| [12] |
丁华野. 不典型大汗腺增生性病变[J]．临床与实验病理学杂志，2014，30(3)：237-240.
|
| [13] |
D’Arcy C, Quinn C. Apocrine lesions of the breast：part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast[J]. J Clin Pathol，2019，72(1)：1-6.
|
| [14] |
李桂梅，谭洋，朱芸，等. 伴单纯性大汗腺分化的浸润性乳腺癌1例[J]．诊断病理学杂志，2020，27(2)：107-110.
|
| [15] |
董燕燕，刘云霄. 乳腺大汗腺型导管原位癌累及硬化性腺病的临床病理分析[J]．中国实用医刊，2018，45(13)：4-8.
|
| [16] |
McGhan LJ, McCullough AE, Protheroe CA, et al. Androgen receptor-positive triple negative breast cancer：a unique breast cancer subtype[J]. Ann Surg Oncol，2014，21(2)：361-367.
|
| [17] |
Naderi A, Meyer M. Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer[J]. Breast Cancer Res，2012，14(4)：R111.
|
| [18] |
Gerhard R，Costa JL，Schmitt F. Benign and malignant apocrine lesions of the breast[J]. Expert Rev Anticancer Ther，2012，12(2)：215-221.
|
| [19] |
Gromov P, Espinoza JA, Talman ML，et al. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast[J]. PLoS One，2014，9(11)：e112024.
|
| [20] |
杨文涛. 关于WHO乳腺肿瘤分类第五版的解读[J]．中华医学信息导报，2020，35(13)：6.
|
| [21] |
吴焕文，刘旭光，滕良红，等. 乳腺大汗腺病变中的肌上皮细胞改变2例临床病理观察[J]．诊断病理学杂志，2018，25(3)：165-169.
|